Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...
The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...
The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...
The drug, suzetrigine, made by Boston-based Vertex Pharmaceuticals and to be sold as Journavx, works only on nerves outside ...
FDA approves new type of non-opioid pain medication in two decades - The new drug will be many times more expensive than a ...